Should everyone get a COVID booster? Experts divided
The United States is set to become the latest country to widen COVID booster eligibility beyond the immunocompromised, elderly and high risk.
Nov 18, 2021
0
1
The United States is set to become the latest country to widen COVID booster eligibility beyond the immunocompromised, elderly and high risk.
Nov 18, 2021
0
1
For low- and middle-income countries, a COVID-19 vaccination program built on prompt procurement, effective on-the-ground distribution, and a rapid pace of vaccination (the total number of doses given daily) is likely to ...
Oct 29, 2021
1
53
When new Emory University faculty member Natalie Dean posted a primer on Twitter last year to demystify vaccine efficacy, she earned herself a fanbase outside the scientific community. Biostatisticians like Dean are challenged ...
Oct 22, 2021
0
11
An expert review by an international group of scientists, including some at the WHO and FDA, concludes that, even for the delta variant, vaccine efficacy against severe COVID is so high that booster doses for the general ...
Sep 13, 2021
0
516
As a medical student working with Alberta Health Services to vaccinate people against COVID-19, I have been asked my fair share of questions about the COVID-19 vaccines—from the need for booster doses to rare side effects.
Sep 2, 2021
0
2
As countries around the world race to increase COVID-19 vaccination rates within their populations, there are reports of fully immunized individuals experiencing breakthrough infections, particularly in the US and UK. A breakthrough ...
Aug 24, 2021
0
151
The availability of vaccines provides a promising solution to contain the COVID-19 pandemic. However, it remains unclear whether the large-scale vaccination can succeed in containing the COVID-19 pandemic and how soon. According ...
Aug 10, 2021
0
6
Interim data from a phase 3 trial of a COVID-19 vaccine developed in China (CoronaVac) suggests that two doses offer 83.5% protection against symptomatic COVID-19.
Jul 9, 2021
0
4
Vaccines such as Pfizer, Moderna, Johnson & Johnson and AstraZeneca are designed to prevent severe Coronavirus-19 Disease (COVID-19) due to acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and are highly efficacious. ...
Jul 7, 2021
0
2
When people say that we won't reach "herd immunity" to COVID-19, they are usually referring to an ideal of "full" population immunity: when so many people are immune that, most of the time, there is no community transmission.
Jun 14, 2021
0
2